OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
COVID-19 and investments will shape the outsourcing industry for the near term.
Advances in technology are accelerating the development and manufacture of subunit vaccines.
October 07, 2021
The agency’s human medicines committee approved an additional site in West Point, Pa. in the United States for the manufacture of Janssen’s COVID-19 vaccine.
The agency has concluded that an extra dose of the COVID-19 vaccines may be given to those individuals with severely weakened immune systems.
The agency received a marketing authorization application a monoclonal antibody treatment for COVID-19 patients.
October 06, 2021
The test developed by Luas Diagnostics and Bond Digital uses a smartphone app to enhance a 15-minute COVID-19 immunity test.
October 05, 2021
Merck and Ridgeback Biotherapeutics' oral antiviral medication reduced the risk of hospitalization or death from COVID-19 by 50% relative to placebo in a Phase III clinical study.
October 03, 2021
Reformulation strategies are useful tools for more than just stretching out the potential return on investment for a product.
October 01, 2021
Appili Therapeutics and AiPharma Global Holdings announced a strategic alliance to advance the global development of a broad-spectrum antiviral treatment in oral tablet form for the treatment of COVID-19.
Rengeron’s trial found that REGEN-COV significantly reduced viral load of patients with COVID-19.
EMA's CHMP is going to perform an accelerated assessment of data submitted by Moderna regarding the use of a booster dose of Spikevax.
September 24, 2021
Biden outlines a plan to end the pandemic in a virtual global conference.